169 related articles for article (PubMed ID: 33766343)
1. A carboxymethyl lentinan layer by layer self-assembly system as a promising drug chemotherapeutic platform.
Cai D; Shi L; Long R; Ren G; Wang S; Liu Y
Carbohydr Polym; 2021 Jun; 261():117847. PubMed ID: 33766343
[TBL] [Abstract][Full Text] [Related]
2. Poly-L-ornithine/fucoidan-coated calcium carbonate microparticles by layer-by-layer self-assembly technique for cancer theranostics.
Wang P; Kankala RK; Fan J; Long R; Liu Y; Wang S
J Mater Sci Mater Med; 2018 May; 29(5):68. PubMed ID: 29748879
[TBL] [Abstract][Full Text] [Related]
3. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
[TBL] [Abstract][Full Text] [Related]
4. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility.
Feng W; Zhou X; He C; Qiu K; Nie W; Chen L; Wang H; Mo X; Zhang Y
J Mater Chem B; 2013 Nov; 1(43):5886-5898. PubMed ID: 32261055
[TBL] [Abstract][Full Text] [Related]
5. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
6. Smart MSN-Drug-Delivery System for Tumor Cell Targeting and Tumor Microenvironment Release.
Dong JH; Ma Y; Li R; Zhang WT; Zhang MQ; Meng FN; Ding K; Jiang HT; Gong YK
ACS Appl Mater Interfaces; 2021 Sep; 13(36):42522-42532. PubMed ID: 34463488
[TBL] [Abstract][Full Text] [Related]
7. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
[TBL] [Abstract][Full Text] [Related]
8. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
9. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
10. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.
Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S
AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882
[TBL] [Abstract][Full Text] [Related]
12. Layer-by-Layer (LBL) Self-Assembled Biohybrid Nanomaterials for Efficient Antibacterial Applications.
Wu Y; Long Y; Li QL; Han S; Ma J; Yang YW; Gao H
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17255-63. PubMed ID: 26192024
[TBL] [Abstract][Full Text] [Related]
13. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
14. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
15. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
Li X; Xie C; Xia H; Wang Z
Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
17. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Narayan R; Gadag S; Cheruku SP; Raichur AM; Day CM; Garg S; Manandhar S; Pai KSR; Suresh A; Mehta CH; Nayak Y; Kumar N; Nayak UY
Carbohydr Polym; 2021 Jun; 261():117893. PubMed ID: 33766378
[TBL] [Abstract][Full Text] [Related]
19. Mannosylated poly(acrylic acid)-coated mesoporous silica nanoparticles for anticancer therapy.
Lee H; Choi M; Kim HE; Jin M; Jeon WJ; Jung M; Yoo H; Won JH; Na YG; Lee JY; Seong H; Lee HK; Cho CW
J Control Release; 2022 Sep; 349():241-253. PubMed ID: 35798094
[TBL] [Abstract][Full Text] [Related]
20. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
